Centro de Investigación Médica Aplicada-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2015

  1. In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone

    Leukemia, Vol. 29, Núm. 3, pp. 705-714